Y-mAbs Therapeutics Inc. (YMAB)

AI Score

Unlock

4.13

0.01 (0.24%)

At close: Apr 24, 2025, 3:59 PM

4.00

-3.15%

Pre-market: Apr 25, 2025, 08:04 AM EDT

Y-mAbs Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017
Revenue	26.5M	18.46M	22.8M	19.93M	23.36M	20.45M	20.75M	20.25M	31.45M	12.54M	10.8M	10.49M	9.6M	8.96M	10.95M	5.38M	20.75M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	7.84M	2.25M	3.01M	2.15M	2.04M	2.65M	4.65M	2.08M	2.02M	2.48M	1.24M	1.83M	1.46M	550K	410K	93K	2.2M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	18.65M	16.21M	19.78M	17.78M	21.32M	17.81M	16.1M	18.17M	29.43M	10.06M	9.56M	8.65M	8.14M	8.41M	10.54M	5.29M	18.55M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-5.94M	-8.57M	-9.79M	-6.91M	-3.2M	-7.75M	-7.22M	-7.5M	-1.15M	-26.02M	-39.95M	-27.7M	-35.76M	-28.7M	-22.71M	-28.26M	-20.09M	-32.64M	-40.45M	-26.75M	-23.76M	-24.36M	-18.63M	-16.25M	-14.08M	-11.41M	-10.26M	-7.48M	-9.28M	-3.84M	-3.06M	-3.06M
Interest Income	n/a	1.92M	640K	439K	n/a	189K	1.1M	1.11M	n/a	1.51M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	59K	568K	n/a	n/a	n/a	319K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	-7.54M	-6.65M	-9.15M	-6.47M	-793K	-7.56M	-6.12M	-6.39M	1.16M	-27.53M	-41.13M	-28.07M	-36.89M	-28.86M	-22.94M	33.41M	-19.93M	-32.83M	-40.39M	-26.18M	-23.14M	-23.92M	-18.04M	-15.93M	-14.06M	-11.43M	-10.3M	-7.48M	-9.25M	-3.83M	-3.04M	-3.04M
Net Income	-6.79M	-7M	-9.25M	-6.63M	-988K	-7.75M	-6.3M	-5.1M	1.16M	-29.04M	-42.32M	-28.44M	-36.89M	-28.86M	-22.94M	33.41M	-19.93M	-32.83M	-40.39M	-26.18M	-23.14M	-23.92M	-18.04M	-15.93M	-14.06M	-11.43M	-10.3M	-7.48M	-9.25M	-3.83M	-3.04M	-3.04M
Selling & General & Admin	12.38M	13.61M	17.23M	11.43M	11.13M	10.2M	11.27M	12.25M	10.79M	13.63M	23.08M	13.44M	15.14M	13.99M	13.47M	11.97M	14.63M	11.64M	10.39M	8.13M	6.93M	4.7M	4.14M	3.74M	3.04M	2.68M	1.97M	1.27M	2.65M	766K	760.5K	760.5K
Research & Development	12.21M	11.17M	12.34M	13.27M	13.39M	15.36M	12.05M	13.42M	19.79M	22.45M	26.42M	22.91M	28.76M	23.13M	19.78M	21.58M	24.01M	21M	30.06M	18.62M	16.83M	19.66M	14.49M	12.51M	11.04M	8.73M	8.29M	6.2M	6.63M	3.08M	2.3M	2.3M
Other Expenses	n/a	n/a	-170K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	210K	n/a	n/a	62.01M	2.2M	n/a	n/a	n/a	n/a	n/a	n/a	319K	n/a	-11K	n/a	n/a	21K	15K	n/a	n/a
Operating Expenses	24.59M	24.78M	29.57M	24.69M	24.52M	25.56M	23.32M	25.67M	30.58M	36.08M	49.5M	36.35M	43.9M	37.12M	33.25M	33.55M	38.64M	32.64M	40.45M	26.75M	23.76M	24.36M	18.63M	16.25M	14.08M	11.41M	10.26M	7.48M	9.28M	3.84M	3.04M	3.04M
Interest Expense	n/a	n/a	n/a	n/a	1.29M	n/a	n/a	n/a	n/a	1.51M	1.19M	373K	1.14M	154K	225K	338K	598K	191K	n/a	n/a	1.98M	437K	598K	319K	n/a	n/a	n/a	4K	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	32.43M	27.03M	32.59M	26.84M	26.56M	28.2M	27.97M	27.75M	32.6M	38.55M	50.74M	38.18M	45.36M	37.67M	33.66M	33.64M	38.64M	32.64M	40.45M	26.75M	23.76M	24.36M	18.63M	16.25M	14.08M	11.41M	10.26M	7.48M	9.28M	3.84M	3.04M	3.04M
Income Tax Expense	-752K	346K	100K	160K	195K	187K	179K	-1.29M	n/a	1.51M	1.19M	373K	1.14M	n/a	-216K	338K	2.09M	n/a	n/a	n/a	-79K	n/a	n/a	-19K	n/a	n/a	n/a	-7.48M	-9.28M	-3.84M	23K	23K
Shares Outstanding (Basic)	44.88M	44.63M	44.02M	43.78M	43.63M	43.62M	43.66M	43.67M	43.67M	43.69M	43.72M	43.71M	43.6M	43.6M	43.28M	41.87M	41.87M	40.19M	39.97M	39.67M	37.97M	34.37M	34.19M	34.19M	34.19M	27.33M	32.63M	33.29M	33.29M	33.29M	17.64M	17.64M
Shares Outstanding (Diluted)	44.88M	44.63M	44.02M	43.78M	43.63M	43.62M	43.66M	43.67M	44.69M	43.72M	43.72M	43.71M	43.6M	43.6M	43.57M	44.38M	44.38M	40.19M	39.97M	39.75M	39.75M	34.37M	34.19M	34.19M	34.19M	27.33M	32.63M	33.29M	33.29M	33.29M	17.64M	17.64M
EPS (Basic)	-0.15	-0.16	-0.21	-0.15	-0.02	-0.18	-0.14	-0.12	0.03	-0.66	-0.97	-0.65	-0.85	-0.66	-0.53	0.80	-0.48	-0.82	-1.01	-0.66	-0.61	-0.7	-0.53	-0.47	-0.41	-0.42	-0.32	-0.22	-0.28	-0.11	-0.17	-0.17
EPS (Diluted)	-0.15	-0.16	-0.21	-0.15	-0.02	-0.18	-0.14	-0.12	0.03	-0.66	-0.97	-0.65	-0.85	-0.66	-0.53	0.75	-0.45	-0.82	-1.01	-0.66	-0.58	-0.7	-0.53	-0.47	-0.41	-0.42	-0.32	-0.22	-0.28	-0.11	-0.17	-0.17
EBITDA	-5.94M	-8.45M	-9.64M	-6.75M	-3.04M	-7.58M	-7M	-7.5M	-923K	-25.79M	-39.95M	-27.5M	-35.47M	-28.56M	-22.5M	-28.13M	-19.98M	-32.55M	-40.35M	-26.66M	-23.68M	-24.31M	-18.61M	-16.23M	-14.06M	-11.41M	-10.25M	n/a	n/a	n/a	23K	23K
EBIT	-5.94M	-8.57M	-9.79M	-6.91M	-3.2M	-7.75M	-7.22M	-7.5M	-1.15M	-26.02M	-41.13M	-27.7M	-35.76M	-28.7M	-22.71M	33.75M	-20.09M	-32.64M	-40.45M	-26.75M	-23.76M	-24.36M	-18.63M	-16.25M	-14.08M	-11.41M	-10.26M	-7.48M	-9.28M	-3.84M	-3.06M	-3.06M
Depreciation & Amortization	n/a	121K	153K	159K	161K	168K	224K	182K	230K	226K	188K	195K	291K	145K	216K	130K	117K	93K	100K	86K	79K	48K	20K	19K	14K	9K	6K	7.48M	9.28M	3.84M	3.06M	3.06M